記住我
Cytogenetic and Genome Research
Zhou Y.a· Lu X.a· Zhang Y.b· Ge Y.a· Xu Y.c· Wu L.d· Jiang Y.aaUnited Diagnostic and Research Center for Clinical Genetics, Women and Children’s Hospital, School of Medicine and School of Public Health, Xiamen University, Xiamen, China
bDepartment of Medical Ultrasonics, Women and Children’s Hospital, School of Medicine, Xiamen University, Xiamen, China
cDepartment of Prenatal Diagnosis, Women and Children’s Hospital, School of Medicine, Xiamen University, Xiamen, China
dDepartment of Gynecology, Women and Children’s Hospital, School of Medicine, Xiamen University, Xiamen, China
Log in to MyKarger to check if you already have access to this content.
Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price. Rent via DeepDyve Unlimited fulltext viewing of this article Organize, annotate and mark up articles Printing and downloading restrictions apply Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more Select* The final prices may differ from the prices shown due to specifics of VAT rules.
Article / Publication DetailsFirst-Page Preview
Received: August 29, 2022
Accepted: December 07, 2022
Published online: March 10, 2023
Number of Print Pages: 11
Number of Figures: 2
Number of Tables: 3
ISSN: 1424-8581 (Print)
eISSN: 1424-859X (Online)
For additional information: https://www.karger.com/CGR
AbstractFetal cystic hygroma (CH) is associated with poor prognosis and chromosomal anomalies. Recent studies have suggested that the genetic background of affected fetuses is essential for predicting pregnancy outcomes. However, the detection performance of different genetic approaches for the etiological diagnosis of fetal CH remains unclear. In this study, we aimed to compare the diagnostic efficiency of karyotyping and chromosomal microarray analysis (CMA) in a local fetal CH cohort, and tried to propose an optimized testing strategy that may help improve the cost-effectiveness of disease management. We reviewed all pregnancies that underwent invasive prenatal diagnosis between January 2017 and September 2021 at one of the largest prenatal diagnostic centers in Southeast China. We collected cases identified by the presence of fetal CH. Prenatal phenotypes and laboratory records of these patients were audited, collated, and analyzed. The detection rates of karyotyping and CMA were compared, and the concordance rate of these two methods was calculated. A total of 157 fetal CH cases were screened from 6,059 patients who underwent prenatal diagnosis. Diagnostic genetic variants were identified in 44.6% (70/157) of the cases. Karyotyping, CMA, and whole-exome sequencing (WES) identified pathogenic genetic variants in 63, 68, and 1 case, respectively. The Cohen’s κ coefficient between karyotyping and CMA was 0.96, with a concordance of 98.0%. Of the 18 cases in which cryptic copy number variants <5 Mb were detected by CMA, 17 were interpreted as variants of uncertain significance, and the remaining cases were interpreted as pathogenic. Trio exome sequencing revealed a pathogenic homozygous splice site mutation in the PIGN gene in a case undiagnosed by CMA and karyotyping. Our study demonstrated that chromosomal aneuploidy abnormalities are the main genetic cause of fetal CH. Based on this, we recommend karyotyping combined with rapid aneuploidy detection as a first-tier approach for the genetic diagnosis of fetal CH. WES and CMA could improve the diagnostic yield when routine genetic tests fail to determine the cause of fetal CH.
© 2023 S. Karger AG, Basel
References Association for Clinical Cytogenetics and Clinical Molecular Genetics Society. QF-PCR for the diagnosis of aneuploidy. Best Practice Guidelines (2012) v3.01. 2012. Bourque DK, Cloutier M, Kernohan KD, Bareke E, Grynspan D, Michaud J, et al., Care4Rare Canada Consortium. Neu-Laxova syndrome presenting prenatally with increased nuchal translucency and cystic hygroma: the utility of exome sequencing in deciphering the diagnosis. Am J Med Genet A. 2019;179(5):813–6. Felice V, Abhyankar A, Jobanputra V. Prenatal diagnosis by whole exome sequencing in fetuses with ultrasound abnormalities. Methods Mol Biol. 2019;1885:267–85. Fiorentino F, Napoletano S, Caiazzo F, Sessa M, Bono S, Spizzichino L, et al. Chromosomal microarray analysis as a first-line test in pregnancies with a priori low risk for the detection of submicroscopic chromosomal abnormalities. Eur J Hum Genet. 2013;21(7):725–30. Ganapathy R, Guven M, Sethna F, Vivekananda U, Thilaganathan B. Natural history and outcome of prenatally diagnosed cystic hygroma. Prenat Diagn. 2004;24(12):965–8. Graesslin O, Derniaux E, Alanio E, Gaillard D, Vitry F, Quereux C, et al. Characteristics and outcome of fetal cystic hygroma diagnosed in the first trimester. Acta Obstet Gynecol Scand. 2007;86(12):1442–6. Grande M, Jansen FAR, Blumenfeld YJ, Fisher A, Odibo AO, Haak MC, et al. Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015;46(6):650–8. Hamilton SJ, Waters JJ. Completely discrepant results between prenatal QF-PCR rapid aneuploidy testing and cultured cell karyotyping obtained from CVS: lessons from UK audit and re-audit of 22,221 cases. Prenat Diagn. 2012;32(9):909–11. Jiang Y, Wu L, Ge Y, Zhang J, Huang Y, Wu Q, et al. Clinical utility of the prenatal BACs-on-beads assay in invasive prenatal diagnosis. Front Genet. 2021;12:789625. Kharrat R, Yamamoto M, Roume J, Couderc S, Vialard F, Hillion Y, et al. Karyotype and outcome of fetuses diagnosed with cystic hygroma in the first trimester in relation to nuchal translucency thickness. Prenat Diagn. 2006;26(4):369–72. Lau ET, Tang L, Wong C, Yung Hang L, Ghosh A, Leung WC, et al. Assessing discrepant findings between QF-PCR on uncultured prenatal samples and karyotyping on long-term culture. Prenat Diagn. 2009;29(2):151–5. Levy AT, Berghella V, Al-Kouatly HB. Outcome of 45,X fetuses with cystic hygroma: a systematic review. Am J Med Genet A. 2021;185(1):26–32. Low KJ, Abdel-Fattah S, Barton J, Crowne EC, Denbow M, Lerpiniere N, et al. Rare XXY/XX mosaicism in a phenotypic male presenting as cystic hygroma in the first trimester. Clin Dysmorphol. 2017;26(2):107–9. Mack LM, Lee W, Mastrobattista JM, Belfort MA, Van den Veyver IB, Shamshirsaz AA, et al. Are first trimester nuchal septations independent risk factors for chromosomal anomalies? J Ultrasound Med. 2017;36(1):155–61. Malone CM, Mullers S, Kelliher N, Dalrymple J, O'Beirnes J, Flood K, et al. Euploid first-trimester cystic hygroma: a more benign entity than previously thought? Fetal Diagn Ther. 2021;48(9):667–71. Malone FD, Ball RH, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, et al., FASTER Trial Research Consortium. First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome. Obstet Gynecol. 2005;106(2):288–94. Monaghan KG, Leach NT, Pekarek D, Prasad P, Rose NC, Guidelines C, ACMG Professional Practice and Guidelines Committee. The use of fetal exome sequencing in prenatal diagnosis: a points to consider document of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2020;22(4):675–80. Ozcan HC, Uğur MG, Balat O, Sucu S, Bayramoğlu Tepe N, Ozturk E, et al. Analysis of cystic hygroma diagnosed in the prenatal period: 5-years' experience at a tertiary hospital in Southeastern Turkey. J Matern Fetal Neonatal Med. 2019;32(11):1800–5. Pan M, Han J, Zhen L, Yang X, Li R, Liao C, et al. Prenatal diagnosis of fetuses with increased nuchal translucency using an approach based on quantitative fluorescent polymerase chain reaction and genomic microarray. Eur J Obstet Gynecol Reprod Biol. 2016;197:164–7. Pan M, Liu YN, Xu LL, Li DZ. First-trimester cystic hygroma and neurodevelopmental disorders: the association to remember. Taiwan J Obstet Gynecol. 2020;59(6):960–2. Petrovski S, Aggarwal V, Giordano JL, Stosic M, Wou K, Bier L, et al. Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study. Lancet. 2019;393(10173):758–67. Ples L, Sima RM, Nedelea F, Moga M. First prenatal diagnosis of a Niemann-Pick disease type C2 revealed by a cystic hygroma: a case report and review of the literature. Front Endocrinol (Lausanne). 2018;9:292. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al., ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24. Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020;22(2):245–57. Rose NC, Kaimal AJ, Dugoff L, Norton ME. Screening for fetal chromosomal abnormalities: ACOG practice bulletin summary, number 226. Obstet Gynecol. 2020;136:859–67. Scholl J, Durfee SM, Russell MA, Heard AJ, Iyer C, Alammari R, et al. First-trimester cystic hygroma: relationship of nuchal translucency thickness and outcomes. Obstet Gynecol. 2012;120(3):551–9. Sebire NJ, Snijders RJM, Brown R, Southall T, Nicolaides KH. Detection of sex chromosome abnormalities by nuchal translucency screening at 10–14 weeks. Prenat Diagn. 1998;18(6):581–4. Shaffer LG, Rosenfeld JA, Dabell MP, Coppinger J, Bandholz AM, Ellison JW, et al. Detection rates of clinically significant genomic alterations by microarray analysis for specific anomalies detected by ultrasound. Prenat Diagn. 2012;32(10):986–95. Sparks TN, Lianoglou BR, Adami RR, Pluym ID, Holliman K, Duffy J, et al., University of California Fetal-Maternal Consortium, University of California San Francisco Center for Maternal–Fetal Precision Medicine. Exome sequencing for prenatal diagnosis in nonimmune hydrops fetalis. N Engl J Med. 2020;383(18):1746–56. Sun L, Yang X, Xu Y, Sun S, Wu Q. Prenatal diagnosis of familial recessive PIGN mutation associated with multiple anomalies: a case report. Taiwan J Obstet Gynecol. 2021;60(3):530–3. Tolusso LK, Hazelton P, Wong B, Swarr DT. Beyond diagnostic yield: prenatal exome sequencing results in maternal, neonatal, and familial clinical management changes. Genet Med. 2021;23(5):909–17. van Huizen ME, Pighetti M, Bijlsma EK, Knegt AC, Bilardo CM. Increased nuchal translucency thickness: a marker for chromosomal and genetic disorders in both offspring and parents. Ultrasound Obstet Gynecol. 2005;26(7):793–4. Wan S, Zheng Y, Dang Y, Song T, Chen B, Zhang J. Prenatal diagnosis of 17q12 microdeletion and microduplication syndrome in fetuses with congenital renal abnormalities. Mol Cytogenet. 2019;12:19. Waters JJ, Walsh S, Levett LJ, Liddle S, Akinfenwa Y. Complete discrepancy between abnormal fetal karyotypes predicted by QF-PCR rapid testing and karyotyped cultured cells in a first-trimester CVS. Prenat Diagn. 2006;26(10):892–7. Wou K, Weitz T, McCormack C, Wynn J, Spiegel E, Giordano J, et al. Parental perceptions of prenatal whole exome sequencing (PPPWES) study. Prenat Diagn. 2018;38(11):801–11. Xing Y, Holder JL Jr, Liu Y, Yuan M, Sun Q, Qu X, et al. Prenatal diagnosis of Wolf-Hirschhorn syndrome: from ultrasound findings, diagnostic technology to genetic counseling. Arch Gynecol Obstet. 2018;298(2):289–95. Yakıştıran B, Altınboğa O, Canpolat E, Çakar EŞ, Çelen Ş, Çağlar AT, et al. Analysis of cystic hygroma diagnosed in the first trimester: single-center experience. J Turk Ger Gynecol Assoc. 2020;21(2):107–10. Zhen L, Fan SS, Huang LY, Pan M, Han J, Yang X, et al. Prenatal diagnosis of Wolf-Hirschhorn syndrome: ultrasonography and molecular karyotyping results. Eur J Obstet Gynecol Reprod Biol. 2018;225:19–21. Zhou CX, Zhu XY, Zhu YJ, Gu LL, He LL, Liu W, et al. Prenatal features of 17q12 microdeletion and microduplication syndromes: a retrospective case series. Taiwan J Obstet Gynecol. 2021;60(2):232–7. Article / Publication DetailsFirst-Page Preview
Received: August 29, 2022
Accepted: December 07, 2022
Published online: March 10, 2023
Number of Print Pages: 11
Number of Figures: 2
Number of Tables: 3
ISSN: 1424-8581 (Print)
eISSN: 1424-859X (Online)
For additional information: https://www.karger.com/CGR
Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
留言 (0)